TNF and Parkinson disease: This conclusion may be useful for new therapeutic approaches specifically targeting TNF-α to prevent (prophylactic) or to slow (at diagnosis) PD, as well as potentially other neurodegenerative diseases sharing TNF-α as a contributor to neurodegenerative progression.